Generics Fight Nifedipine Direct Purchaser Class

Law360, New York (October 23, 2007, 12:00 AM EDT) -- Biovail Corp., Elan Corp. plc and Teva Pharmaceuticals Ltd. have opposed certification of a direct purchaser class in the multidistrict litigation a slew of distributors and stores filed against them for allegedly divvying up the market for a generic hypertension drug to keep prices high.

The companies filed papers with the U.S. District Court for the District of Columbia on Monday, rejecting the plaintiffs' claim that the companies' challenges to the certification of a nationwide class of direct purchasers suing under the Sherman Act didn't make...
To view the full article, register now.